Phase 1 Clinical Trials
The MEU is a UK leader in First in Man studies. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Phase 1 programme.
Therapeutic Areas
The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase 1 studies in many other therapeutic areas.
Facilities
State-of-the-art, hospital-based facilities including 36 inpatient beds with cardiac and telemetry monitoring, a pharmacy, clinical assessment suite, bronchoscopy unit and numerous outpatient/consultant rooms.
Recruitment
Contact us today to sense-check your protocol synopsis against our ICARUS phenotyped database of over 17,000 clinical trial volunteers. We can run inclusion/exclusion criteria in minutes, instantly checking the phenotyped data across multiple therapeutic fields.
A leader in First-In-Patient studies for over twenty years
Latest News
2019 in Review
- Posted by The MEU
- On 28th January 2020
In 2019, we completed 23 clinical trials in the following therapeutic areas: IPF, Asthma, Atopic Dermatitis, COPD, Psoriasis, Alpha-1-Antitrypsin Deficiency, Hypertension
Clinical Trials Europe Conference 2019 in Barcelona
- Posted by The MEU
- On 13th November 2019
We will be attending the annual Clinical Trials Europe Conference 2019 in Barcelona next week (formerly known as Partnerships in Clinical Trials...
MEU at The EADV Congress Madrid 2019
- Posted by The MEU
- On 10th October 2019
MEU are proudly supporting dermatological drug development at the EADV Congress in Madrid this week. The European Academy of Dermatology and Venereology...